Skip Header

 
Contribute Send feedback
Read comments (1) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9HAU4 (SMUF2_HUMAN)

Last modified June 16, 2009. Version 85. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    E3 ubiquitin-protein ligase SMURF2
      Short name=hSMURF2
    EC=6.3.2.-
Alternative name(s):
    SMAD ubiquitination regulatory factor 2
    SMAD-specific E3 ubiquitin-protein ligase 2
Gene names
Name: SMURF2
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length748 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Interacts with SMAD1 and SMAD7 in order to trigger their ubiquitination and proteasome-dependent degradation. In addition, interaction with SMAD7 activates autocatalytic degradation, which is prevented by interaction with SCYE1. Forms a stable complex with the TGF-beta receptor-mediated phosphorylated SMAD2 and SMAD3. In this way, SMAD2 may recruit substrates, such as SNON, for ubiquitin-mediated degradation. Enhances the inhibitory activity of SMAD7 and reduces the transcriptional activity of SMAD2. Coexpression of SMURF2 with SMAD1 results in considerable decrease in steady-state level of SMAD1 protein and a smaller decrease of SMAD2 level. Ref.5 Ref.6

Pathway

Protein modification; protein ubiquitination.

Subunit structure

Interacts (via WW domains) with SMAD1. Interacts (via WW domains) with SMAD2 (via PY-motif). Interacts (via WW domains) with SMAD3 (via PY-motif). Interacts with SMAD6. Interacts with SMAD7 (via PY-motif). Does not interact with SMAD4; SMAD4 lacks a PY-motif. Interacts with SCYE1. Ref.5 Ref.8 Ref.9

Subcellular location

Nucleus. Cytoplasm. Cell membrane. Membrane raft. Note: Cytoplasmic in the presence of SMAD7. Co-localizes with CAV1, SMAD7 and TGF-beta receptor in membrane rafts. Ref.6

Tissue specificity

Widely expressed.

Domain

The second and third WW domains are responsible for interaction with the PY-motif of R-SMAD (SMAD1, SMAD2 and SMAD3). Ref.11

The C2 domain is involved in autoinhibition of the catalytic activity by interacting with the HECT domain. Ref.11

Sequence similarities

Contains 1 C2 domain.

Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.

Contains 3 WW domains.

Binary interactions

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 748748E3 ubiquitin-protein ligase SMURF2
PRO_0000120329

Regions

Domain1 – 9898C2
Domain157 – 19034WW 1
Domain251 – 28434WW 2
Domain297 – 33034WW 3
Domain414 – 748335HECT

Sites

Active site7161Glycyl thioester intermediate By similarity

Experimental info

Mutagenesis291F → A: Increases autoubiquitination; when associated with A-30. Ref.11
Mutagenesis301F → A: Increases autoubiquitination; when associated with A-29. Ref.11
Mutagenesis561T → A: Increases autoubiquitination; when associated with A-57. Ref.11
Mutagenesis571L → A: Increases autoubiquitination; when associated with A-56. Ref.11
Mutagenesis251 – 28434Missing: Abolishes interaction with SMAD2 and SMAD7. Ref.1
Mutagenesis297 – 33034Missing: Abolishes interaction with SMAD7. Ref.1
Mutagenesis5351W → A: Loss of catalytic activity. Ref.9
Mutagenesis5351W → D: Loss of catalytic activity. Ref.9
Mutagenesis5471H → A: Partial loss of catalytic activity. Ref.9
Mutagenesis5471H → F or I: Activates autocatalytic activity. Ref.9
Mutagenesis5811Y → A: Loss of catalytic activity. Ref.9
Mutagenesis7161C → A: Increases Smad7-bound TGF-beta receptors in membrane rafts. Ref.6 Ref.2 Ref.3
Mutagenesis7161C → G: Loss of activity. Loss of ability to ubiquitinate SMAD1 and SMAD2 and no down-regulation of SMAD1 and SMAD2 protein levels. Ref.6 Ref.2 Ref.3
Sequence conflict61G → R in AAG45422. Ref.2

Secondary structure

..................................................................................... 748
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Q9HAU4-1 [UniParc].

Last modified March 1, 2001. Version 1.
Checksum: 3042B443A3755762

FASTA74886,196
        10         20         30         40         50         60 
MSNPGGRRNG PVKLRLTVLC AKNLVKKDFF RLPDPFAKVV VDGSGQCHST DTVKNTLDPK 

        70         80         90        100        110        120 
WNQHYDLYIG KSDSVTISVW NHKKIHKKQG AGFLGCVRLL SNAINRLKDT GYQRLDLCKL 

       130        140        150        160        170        180 
GPNDNDTVRG QIVVSLQSRD RIGTGGQVVD CSRLFDNDLP DGWEERRTAS GRIQYLNHIT 

       190        200        210        220        230        240 
RTTQWERPTR PASEYSSPGR PLSCFVDENT PISGTNGATC GQSSDPRLAE RRVRSQRHRN 

       250        260        270        280        290        300 
YMSRTHLHTP PDLPEGYEQR TTQQGQVYFL HTQTGVSTWH DPRVPRDLSN INCEELGPLP 

       310        320        330        340        350        360 
PGWEIRNTAT GRVYFVDHNN RTTQFTDPRL SANLHLVLNR QNQLKDQQQQ QVVSLCPDDT 

       370        380        390        400        410        420 
ECLTVPRYKR DLVQKLKILR QELSQQQPQA GHCRIEVSRE EIFEESYRQV MKMRPKDLWK 

       430        440        450        460        470        480 
RLMIKFRGEE GLDYGGVARE WLYLLSHEML NPYYGLFQYS RDDIYTLQIN PDSAVNPEHL 

       490        500        510        520        530        540 
SYFHFVGRIM GMAVFHGHYI DGGFTLPFYK QLLGKSITLD DMELVDPDLH NSLVWILEND 

       550        560        570        580        590        600 
ITGVLDHTFC VEHNAYGEII QHELKPNGKS IPVNEENKKE YVRLYVNWRF LRGIEAQFLA 

       610        620        630        640        650        660 
LQKGFNEVIP QHLLKTFDEK ELELIICGLG KIDVNDWKVN TRLKHCTPDS NIVKWFWKAV 

       670        680        690        700        710        720 
EFFDEERRAR LLQFVTGSSR VPLQGFKALQ GAAGPRLFTI HQIDACTNNL PKAHTCFNRI 

       730        740 
DIPPYESYEK LYEKLLTAIE ETCGFAVE 

« Hide

References

« Hide 'large scale' references
[1]"Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation."
Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H., Thomsen G.H., Wrana J.L.
Mol. Cell 6:1365-1375(2000) [PubMed: 11163210] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF 251-PRO--VAL-284 AND 297-GLY--LEU-330.
[2]"Smurf2 Is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling."
Lin X., Liang M., Feng X.-H.
J. Biol. Chem. 275:36818-36822(2000) [PubMed: 11016919] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF 251-PRO--VAL-284 AND CYS-716.
[3]"Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase."
Zhang Y., Chang C., Gehling D.J., Hemmati-Brivanlou A., Derynck R.
Proc. Natl. Acad. Sci. U.S.A. 98:974-979(2001) [PubMed: 11158580] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF CYS-716.
[4]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Brain.
[5]"TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation."
Bonni S., Wang H.R., Causing C.G., Kavsak P., Stroschein S.L., Luo K., Wrana J.L.
Nat. Cell Biol. 3:587-595(2001) [PubMed: 11389444] [Abstract]
Cited for: FUNCTION, INTERACTION WITH SMAD2; SMAD3 AND SNON.
[6]"Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover."
Di Guglielmo G.M., Le Roy C., Goodfellow A.F., Wrana J.L.
Nat. Cell Biol. 5:410-421(2003) [PubMed: 12717440] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-716.
[7]Erratum
Di Guglielmo G.M., Le Roy C., Goodfellow A.F., Wrana J.L.
Nat. Cell Biol. 5:680-680(2003)
[8]"AIMP1/p43 downregulates TGF-beta signaling via stabilization of smurf2."
Lee Y.S., Han J.M., Son S.H., Choi J.W., Jeon E.J., Bae S.C., Park Y.I., Kim S.
Biochem. Biophys. Res. Commun. 371:395-400(2008) [PubMed: 18448069] [Abstract]
Cited for: INTERACTION WITH SCYE1.
[9]"Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain."
Ogunjimi A.A., Briant D.J., Pece-Barbara N., Le Roy C., Di Guglielmo G.M., Kavsak P., Rasmussen R.K., Seet B.T., Sicheri F., Wrana J.L.
Mol. Cell 19:297-308(2005) [PubMed: 16061177] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 369-748, INTERACTION WITH SMAD7, MUTAGENESIS OF TRP-535; HIS-547 AND TYR-581.
[10]"An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2."
Chong P.A., Lin H., Wrana J.L., Forman-Kay J.D.
J. Biol. Chem. 281:17069-17075(2006) [PubMed: 16641086] [Abstract]
Cited for: STRUCTURE BY NMR OF 297-333 IN COMPLEX WITH SMAD7.
[11]"Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain."
Wiesner S., Ogunjimi A.A., Wang H.R., Rotin D., Sicheri F., Wrana J.L., Forman-Kay J.D.
Cell 130:651-662(2007) [PubMed: 17719543] [Abstract]
Cited for: STRUCTURE BY NMR OF 10-140, AUTOINHIBITION BY C2 DOMAIN, MUTAGENESIS OF PHE-29; PHE-30; THR-56 AND LEU-57.
+Additional computationally mapped references.

Cross-references

Sequence databases

AF310676 mRNA. Translation: AAG45422.1.
AF301463 mRNA. Translation: AAG25641.1.
AY014180 mRNA. Translation: AAG50421.1.
BC093876 mRNA. Translation: AAH93876.1.
BC111945 mRNA. Translation: AAI11946.1.
IPIIPI00329664.
RefSeqNP_073576.1.
UniGeneHs.705442

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1ZVDX-ray2.10A369-748[»]
2DJYNMR-A297-333[»]
2JQZNMR-A10-140[»]
ModBaseSearch...

Protein-protein interaction databases

IntActQ9HAU4. 13 interactions.

Proteomic databases

PRIDEQ9HAU4.

Genome annotation databases

EnsemblENSG00000108854. Homo sapiens. [Contig view]
GeneID64750.
KEGGhsa:64750.

Organism-specific databases

GeneCardsGC17M059971.
H-InvDBHIX0039082.
HGNCHGNC:16809. SMURF2.
MIM605532. gene.
PharmGKBPA134985524.
GenAtlasSearch...

Phylogenomic databases

HOGENOMQ9HAU4.
HOVERGENQ9HAU4.

Enzyme and pathway databases

Pathway_Interaction_DBbmppathway. BMP receptor signaling.
tgfbrpathway. TGF-beta receptor signaling.
ReactomeREACT_12034. Signaling by BMP.
REACT_6844. Signaling by TGF beta.

Gene expression databases

ArrayExpressQ9HAU4.
BgeeQ9HAU4.
CleanExHS_SMURF2.
GermOnlineENSG00000108854. Homo sapiens.

Family and domain databases

InterProIPR000008. C2_Ca-dep.
IPR018029. C2_membr_targeting.
IPR000569. HECT.
IPR001202. WW_Rsp5_WWP.
[Graphical view]
PfamPF00168. C2. 1 hit.
PF00632. HECT. 1 hit.
PF00397. WW. 3 hits.
[Graphical view]
SMARTSM00239. C2. 1 hit.
SM00119. HECTc. 1 hit.
SM00456. WW. 3 hits.
[Graphical view]
PROSITEPS50004. C2. 1 hit.
PS50237. HECT. 1 hit.
PS01159. WW_DOMAIN_1. 1 hit.
PS50020. WW_DOMAIN_2. 3 hits.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio66708.
SOURCESearch...

Entry information

Entry nameSMUF2_HUMAN
AccessionPrimary (citable) accession number: Q9HAU4
Secondary accession number(s): Q52LL1, Q9H260
Entry history
Integrated into UniProtKB/Swiss-Prot: December 13, 2001
Last sequence update: March 1, 2001
Last modified: June 16, 2009
This is version 85 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 17

Human chromosome 17: entries, gene names and cross-references to MIM

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PATHWAY comments

Index of metabolic and biosynthesis pathways

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents